Denali Therapeutics
DNLI
#3748
Rank
โ‚ฌ3.21 B
Marketcap
20,27ย โ‚ฌ
Share price
7.20%
Change (1 day)
59.19%
Change (1 year)

EPS for Denali Therapeutics (DNLI)

EPS in 2025 (TTM): -2,58ย โ‚ฌ

According to Denali Therapeutics 's latest financial reports the company's current EPS (TTM) is -2,56ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -2,22ย โ‚ฌ a decrease over its 2023 EPS that were of -0,90ย โ‚ฌ.

EPS history for Denali Therapeutics from 2017 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-2,58ย โ‚ฌ16.62%
2024-2,22ย โ‚ฌ147.12%
2023-0,90ย โ‚ฌ-60%
2022-2,24ย โ‚ฌ8.79%
2021-2,06ย โ‚ฌ-712.82%
20200,34ย โ‚ฌ-118.93%
2019-1,78ย โ‚ฌ402.44%
2018-0,35ย โ‚ฌ-88.89%
2017-3,18ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Organovo
ONVO
-9,93ย โ‚ฌ 287.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
-6,12ย โ‚ฌ 139.06%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
2,36ย โ‚ฌ-192.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
-1,32ย โ‚ฌ-48.48% Jersey